biotech / news / / GlobeNewswire
Kadcyla market is demonstrating robust growth, driven by several critical factors.
Asia-Pacific is the fastest-growing region in the Kadcyla market, outpacing North America’s growth rate.
KEY POINTS
- Tariffs are incentivizing regional manufacturing of ADCs, impacting supply chains and market pricing for Kadcyla.
- Kadcyla market segmentation includes adult male and pediatric patients, not just adult females.
- Home healthcare is an expanding end-user segment for Kadcyla’s administration beyond traditional hospital settings.
COMPANIES
Summarized by Newsio from GlobeNewswire. How we summarize →